Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 86
Selected: 0
NCT IDTitle
NCT06468566Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study
NCT03595644Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer
NCT06050109The Benefits of Continued Use of Ovarian Function Suppression After 5 Years
NCT06020430Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
NCT03801200Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC
NCT07807722Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC
NCT04030845Patient Report Outcome-Reconstruction and Oncoplastic Cohort
NCT03230708Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites
NCT07263347DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes
NCT06854107Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
NCT06713421Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
NCT04074538the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT02623595A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
NCT04735861Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma
NCT06080880Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade
NCT05801133Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors
NCT07002346INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
NCT04214782Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm
NCT05448703A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis
NCT05004441Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer
NCT01271439Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma
NCT05342792Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
NCT03662633Diagnosis Value of SEMA4C in Breast Cancer
NCT06810492The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
NCT06818955Orlistat Overcoming Third-generation EGFR-TKI Resistance
NCT06470256Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma
NCT06280313Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension
NCT05372198Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line
NCT05713994Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
NCT05780372Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT07130643Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer
NCT06402435SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
NCT05520801Primary Hepatobiliary Cancer Cohort of Central China
NCT01863303Epidemiological Study of Colorectal Cancer in WuHan
NCT07264985Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
NCT05021328Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
NCT01899547Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum
NCT05565014Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion
NCT05159167Impact of Baduanjin Qigong Exercise on Fatigue in Patients With NSCLC Undergoing Adjuvant Chemotherapy
NCT07841210Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid Tumors
NCT03482089Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion
NCT05661357Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT05717738Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
NCT06136026Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer
NCT07742800Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
NCT06037733Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy
NCT03286348Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer
NCT04079283Radiomics of Immunotherapeutics Response Evaluation and Prediction
NCT03210064Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients